Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T69487 |
ZK-261557
|
Others | Others |
ZK-261557 is a new oral antiangiogenic molecule that inhibits all known vascular endothelial growth factor receptors. Vatalanib is under investigation for the treatment of solid tumors. |